Literature DB >> 31571174

ABC Transporter-Mediated Multidrug-Resistant Cancer.

Haneen Amawi1, Hong-May Sim2, Amit K Tiwari3, Suresh V Ambudkar4, Suneet Shukla5.   

Abstract

ATP-binding cassette (ABC) transporters are involved in active pumping of many diverse substrates through the cellular membrane. The transport mediated by these proteins modulates the pharmacokinetics of many drugs and xenobiotics. These transporters are involved in the pathogenesis of several human diseases. The overexpression of certain transporters by cancer cells has been identified as a key factor in the development of resistance to chemotherapeutic agents. In this chapter, the localization of ABC transporters in the human body, their physiological roles, and their roles in the development of multidrug resistance (MDR) are reviewed. Specifically, P-glycoprotein (P-GP), multidrug resistance-associated proteins (MRPs), and breast cancer resistance protein (BCRP/ABCG2) are described in more detail. The potential of ABC transporters as therapeutic targets to overcome MDR and strategies for this purpose are discussed as well as various explanations for the lack of efficacy of ABC drug transporter inhibitors to increase the efficiency of chemotherapy.

Entities:  

Keywords:  ABC transporters; Breast cancer resistance protein; Multidrug resistance; Multidrug resistance-associated protein; P-glycoprotein

Mesh:

Substances:

Year:  2019        PMID: 31571174     DOI: 10.1007/978-981-13-7647-4_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  54 in total

Review 1.  Cancer stem cells in colorectal cancer and the association with chemotherapy resistance.

Authors:  Xue Lei; Qinglian He; Ziqi Li; Qian Zou; Pingrong Xu; Haibing Yu; Yuanlin Ding; Wei Zhu
Journal:  Med Oncol       Date:  2021-03-18       Impact factor: 3.064

2.  Resistance to cisplatin in human lung adenocarcinoma cells: effects on the glycophenotype and epithelial to mesenchymal transition markers.

Authors:  Leonardo Marques da Fonseca; Vanessa Amil da Silva; Kelli Monteiro da Costa; Jhenifer Santos Dos Reis; José Osvaldo Previato; Lucia Mendonça Previato; Leonardo Freire-de-Lima
Journal:  Glycoconj J       Date:  2022-02-14       Impact factor: 2.916

3.  ABCC6P1 pseudogene induces ABCC6 upregulation and multidrug resistance in breast cancer.

Authors:  Mahnaz Hashemi; Masoud Golalipour
Journal:  Mol Biol Rep       Date:  2022-08-28       Impact factor: 2.742

4.  Circular RNA circ-CHI3L1.2 modulates cisplatin resistance of osteosarcoma cells via the miR-340-5p/LPAATβ axis.

Authors:  Zehua Zhang; Qiang Zhou; Fei Luo; Rui Zhou; Jianzhong Xu; Jun Xiao; Fei Dai; Lei Song
Journal:  Hum Cell       Date:  2021-06-23       Impact factor: 4.174

5.  Downregulation of breast cancer resistance protein by long-term fractionated radiotherapy sensitizes lung adenocarcinoma to SN-38.

Authors:  Yuqing Wang; Jie Huang; Qiong Wu; Jingjing Zhang; Zhiyuan Ma; Shenglin Ma; Shirong Zhang
Journal:  Invest New Drugs       Date:  2021-01-21       Impact factor: 3.850

Review 6.  The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment.

Authors:  Yanghong Ni; Xiaoting Zhou; Jia Yang; Houhui Shi; Hongyi Li; Xia Zhao; Xuelei Ma
Journal:  Front Cell Dev Biol       Date:  2021-05-20

Review 7.  Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies.

Authors:  Jun Cao; Mengdi Zhang; Bin Wang; Long Zhang; Meiyu Fang; Fangfang Zhou
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

Review 8.  Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection?

Authors:  Dirk Theile; Pauline Wizgall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-08       Impact factor: 3.000

Review 9.  Breast cancer: Muscarinic receptors as new targets for tumor therapy.

Authors:  Alejandro Español; Agustina Salem; Yamila Sanchez; María Elena Sales
Journal:  World J Clin Oncol       Date:  2021-06-24

10.  Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma.

Authors:  Jiaheng Xie; Zhechen Zhu; Yuan Cao; Shujie Ruan; Ming Wang; Jingping Shi
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.